RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common sharesPUBT·Jul 23 at 08:23 PMARTV-0.99%
Major Insider Move Signals Growing Confidence in Artiva BiotherapeuticsTip Ranks·Jul 20 at 09:02 PMARTV-0.99%
RA Capital Management reports $1.43 million purchase of Artiva Biotherapeutics sharesPUBT·Jul 20 at 05:09 PMARTV-0.99%
Artiva Biotherapeutics issues 288,800 RSUs to 17 new hires under inducement planPUBT·Jul 17 at 06:30 AMARTV-0.99%
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ARTV Stock NewsStockTitan·Jul 16 at 10:30 PMARTV-0.99%
RA Capital Management reports purchase of Artiva Biotherapeutics common shares worth $194,237.66PUBT·Jul 14 at 06:01 PMARTV-0.99%
ARTV: AlloNK achieved 71% ACR50 in refractory RA and is advancing to a pivotal phase III trialQuartr·Jun 30 at 06:31 PMARTV-0.99%
Insider Buying: Artiva Biotherapeutics (NASDAQ:ARTV) Director Buys 1,876 Shares of StockMarket Beat·Jun 29 at 04:22 PMARTV-0.99%
Insider Buying: Artiva Biotherapeutics (NASDAQ:ARTV) Director Acquires 31,000 SharesMarket Beat·Jun 29 at 04:07 PMARTV-0.99%
RA Capital Management reports $292,129 Artiva Biotherapeutics common share purchasePUBT·Jun 29 at 03:21 PMARTV-0.99%
Artiva Biotherapeutics to join H.C. Wainwright Cell Therapy Virtual Conference fireside chatPUBT·Jun 23 at 03:05 PMARTV-0.99%
